Oncora Medical
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m |
% growth | - | - | - | (50 %) | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $20.0k | Seed | |
$1.2m | Seed | ||
N/A | N/A | Seed | |
$1.3m | Debt | ||
N/A | Early VC | ||
Total Funding | $1.2m |
Related Content
Recent News about Oncora Medical
EditOncora Medical is a healthcare technology company focused on improving cancer treatment outcomes through the use of real-world data. The company serves healthcare professionals, including physicians, scientists, and healthcare institutions, by providing an intuitive software platform that simplifies workflow, reduces documentation burden, and optimizes treatment. Operating in the oncology market, Oncora Medical's business model revolves around offering software solutions that capture and visualize regulatory-grade real-world data, enabling better healthcare-related decisions. The company generates revenue through software subscriptions and service fees, targeting institutions dedicated to enhancing cancer care quality and outcomes.
Keywords: oncology, real-world data, software platform, cancer treatment, healthcare professionals, workflow optimization, data visualization, patient care, healthcare institutions, advanced reporting tools.